Gene therapy improves or reverses age-related disease in mice
By
Alicia Lasek
Nov 05, 2019
Three longevity-associated genes dramatically improved or completely reversed multiple age-related diseases in mice, researchers have found.
Clinical Briefs for Tuesday, June 30
By
Alicia Lasek
Jun 30, 2020
Owners take rare step to isolate with residents during pandemic … Causal link found between air pollution and elders’ increased mortality … Gene study shows how Alzheimer’s affects genders differently...
Clinical briefs for Thursday, Dec. 3
By
Alicia Lasek
Dec 03, 2020
Program helps senior living operators improve indoor air quality … Kidney disease the leading risk factor for COVID-related hospitalization: study … Gene that protects against osteoarthritis identified...
Clinical briefs for Friday, Aug. 25
By
Kristen Fischer
Aug 25, 2023
No change in prescribing rates for dental-related antibiotics … Spotting adenine in urine could signal kidney failure in people with diabetes … Gene variant that boosts Parkinson’s risk found in...
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.
Gout guidance highlights treat-to-target drug therapy
By
Alicia Lasek
May 12, 2020
Experts strongly recommend moving away from a fixed-dose approach to urate lowering therapy in updated guidelines for 2020.
Study: Updated COVID vaccine is 71 percent effective against hospitalization for older adults
By
Kristen Fischer
Jan 09, 2024
A new study exploring how well the updated COVID-19 vaccines worked in people over the age of 60 had some promising results.
NYU Langone Health institute receives $31M to study aging, vascular risks
By
Kristen Fischer
Apr 15, 2024
The National Institutes of Health has awarded Optimal Aging Institute at NYU Langone Health $31 million for a 10-university cohort to study how vascular risk factors contribute to dementia and other age-related...
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
Clinical briefs for Tuesday, April 6
By
Alicia Lasek
Apr 06, 2021
COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral...